Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

botanical extract DCB-BO1301

A proprietary botanical, galactolipid-enriched extract derived from the edible plant Crassocephalum crepidioides (Zhaohe Cao), with potential anti-inflammatory and antineoplastic activities. Upon oral administration, DCB-BO1301 may inhibit the growth of certain types of tumor cells, although the exact mechanism of action has yet to be fully elucidated.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	Zhaohe Cao-based botanical drug DCB-BO1301
Code name:	DCB BO 1301 DCB BO1301 DCB-BO1301

botanical extract DCB-BO1301

Search NCI's Drug Dictionary